Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Emergency Use Power Could Expand Under Bill Moving To House Floor

Executive Summary

FDA could get the power to issue an Emergency Use Authorization before a pandemic or other emergency, according to legislation reauthorizing the Pandemic and All-Hazards Preparedness Act.
Advertisement

Related Content

Bioterror “Strategic Investor” Initiative Must Be Resolved As House, Senate Pass Dueling Bills
Biosimilar User Fee Negotiations Under Way; Timetable Compressed
PDUFA V: Emerging Sponsor Communication Issue Resolved And Expanded
PDUFA V: Emerging Sponsor Communication Issue Resolved And Expanded
VentureHHS: Government Fund Would Invest In Firms Developing Medical Countermeasures

Topics

Advertisement
UsernamePublicRestriction

Register

PS053735

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel